The efficacy of cefuroxime in the treatment of bacterial meningitis in infants and children.

Abstract

Forty-eight infants and children with bacterial meningitis received daily dosages of cefuroxime ranging from 90 to 300 mg/kg during the first two to four days of treatment and 45 to 149 mg/kg during the subsequent six to eight days of treatment. Cefuroxime was clinically and bacteriologically effective in 40 (83%) of the patients. All strains of Streptococcus pneumoniae, Neisseria meningitidis, and Salmonella typhi were sensitive to cefuroxime. Fourteen strains of Haemophilus influenzae were sensitive, and one was moderately sensitive, to the drug. Nine strains of Staphylococcus aureus were sensitive to cefuroxime, but three were resistant, as was Pseudomonas aeruginosa. No toxicity was encountered.

• Authors: H K Bahaeldin, R Elbaroudy, N Omran
• Journal: Clinical therapeutics (Clin Ther) Vol. 5 Issue 6 Pg. 644-50 ( 1983) ISSN: 0149-2918 [Print] United States
• PMID: 6627291 (Publication Type: Journal Article)

Chemical References

• Cephalosporins
• Cefuroxime

Topics

• Adolescent
• Bacteria (drug effects)
• Cefuroxime (cerebrospinal fluid, therapeutic use)
• Cephalosporins (therapeutic use)
• Child
• Child, Preschool
• Female
• Humans
• Infant
• Infant, Newborn
• Male
• Meningitis (drug therapy, microbiology)